Large gap with delayed quotes
|
Last quote
08/15/2026
-
02:00:00
|
Bid
08/14/2026 -
21:59:59
|
Bid Volume |
Ask
08/14/2026 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
35.74
+0.16
(
+0.45% )
|
35.72
|
200 |
35.74
|
21,500 |
Analysis date: 14.08.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 22.05.2026.
Interest
None
None
No stars since 07.08.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 08.05.2026 at a price of 39.52.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 07.08.2026.
4wk Rel Perf
-10.76%
-10.76%
The four-week dividend-adjusted underperformance versus SP500 is 10.76%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 24.04.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.17%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 5.10%.
Mkt Cap in $bn
46.99
46.99
With a market capitalization >$8bn, MEDLINE is considered a large-cap stock.
G/PE Ratio
0.72
0.72
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
21.27
21.27
The estimated PE is for the year 2028.
LT Growth
15.40%
15.40%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
24
24
Over the last seven weeks, an average of 24 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
32
32
For 1% of index variation, the stock varies on average by 0.32%.
Correlation
0.10
0.10
Stock movements are totally independent of index variations.
Value at Risk
11.28
11.28
The value at risk is estimated at USD 11.28. The risk is therefore 31.58%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
10.03.2026
10.03.2026